Cutler Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-31,800
Closed -$2K 3684
2023
Q3
$2K Buy
+31,800
New +$37.8K ﹤0.01% 3231
2022
Q4
Sell
-17,100
Closed -$1K 4481
2022
Q3
$1K Sell
17,100
-2,700
-14% -$7.07K ﹤0.01% 4458
2022
Q2
$2K Sell
19,800
-12,000
-38% -$31.9K ﹤0.01% 4244
2022
Q1
$9K Sell
31,800
-81,200
-72% -$235K ﹤0.01% 3680
2021
Q4
$12K Sell
113,000
-179,400
-61% -$1.1M ﹤0.01% 3526
2021
Q3
$99K Sell
292,400
-944,400
-76% -$8.08M ﹤0.01% 1919
2021
Q2
$1.99M Buy
1,236,800
+892,600
+259% +$8.77M 0.09% 240
2021
Q1
$104K Buy
344,200
+99,000
+40% +$1.12M 0.01% 1743
2020
Q4
$844K Buy
+245,200
New +$2.73M 0.04% 448

Other funds holding CLOV

Cutler Group's CLOV Position: Q1 2024 in Review

Cutler Group reduced its Clover Health Investments (CLOV) stake by 1.6% in Q1 2024, selling an estimated $268 and leaving 18,000 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Cutler Group first reported a position in CLOV in Q4 2020 and has held it in 14 quarters since. The position peaked at $969K in Q3 2021. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2024.

  • Cutler Group held 18,000 shares of Clover Health Investments worth $14K as of Q1 2024.
  • Cutler Group sold 294 Clover Health Investments shares in Q1 2024, an estimated $268.
  • Clover Health Investments made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1139 holding.
  • Cutler Group first reported a position in Clover Health Investments in Q4 2020 and has held it in 14 quarters since.
  • Cutler Group's Clover Health Investments position peaked at $969K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.